The experimental COVID-19 vaccine codeveloped by the U.S.’s Pfizer, Germany’s BioNTech, and China’s Fosun Pharmaceuticals may reach market as early as this December, according to the chairman of Fosun Group.
“Once the vaccine is proved to be safe and effective [after trial results are posted in November], the vaccine will be made available in the market by December [2020] or January next year,” Guo Guangchang, chair of the parent company of Fosun Pharmaceuticals, said Tuesday at the Fortune Global Forum.
Chinese partner says Pfizer COVID vaccine may reach market by December https://t.co/XHkav6eJXf pic.twitter.com/faAMwRD5Wh
— WBMN Groovin' 24/7 (@RadioBlackOn) October 27, 2020